| Literature DB >> 34663987 |
Anne Philippi1, Sandra Heller2, Ivan G Costa3, Valérie Senée1, Marc Nicolino4, Cécile Julier5, Alexander Kleger6, Markus Breunig2, Zhijian Li3, Gino Kwon2, Ronan Russell7, Anett Illing2, Qiong Lin3, Meike Hohwieler2, Anne Degavre1, Pierre Zalloua8,9, Stefan Liebau10, Michael Schuster11, Johannes Krumm12, Xi Zhang2, Ryan Geusz13, Jacqueline R Benthuysen13, Allen Wang13, Joshua Chiou13, Kyle Gaulton13, Heike Neubauer14, Eric Simon15, Thomas Klein14, Martin Wagner2, Gopika Nair7, Céline Besse16, Claire Dandine-Roulland16, Robert Olaso16, Jean-François Deleuze16, Bernhard Kuster12,17, Matthias Hebrok7, Thomas Seufferlein2, Maike Sander13, Bernhard O Boehm18, Franz Oswald2.
Abstract
Genes involved in distinct diabetes types suggest shared disease mechanisms. Here we show that One Cut Homeobox 1 (ONECUT1) mutations cause monogenic recessive syndromic diabetes in two unrelated patients, characterized by intrauterine growth retardation, pancreas hypoplasia and gallbladder agenesis/hypoplasia, and early-onset diabetes in heterozygous relatives. Heterozygous carriers of rare coding variants of ONECUT1 define a distinctive subgroup of diabetic patients with early-onset, nonautoimmune diabetes, who respond well to diabetes treatment. In addition, common regulatory ONECUT1 variants are associated with multifactorial type 2 diabetes. Directed differentiation of human pluripotent stem cells revealed that loss of ONECUT1 impairs pancreatic progenitor formation and a subsequent endocrine program. Loss of ONECUT1 altered transcription factor binding and enhancer activity and NKX2.2/NKX6.1 expression in pancreatic progenitor cells. Collectively, we demonstrate that ONECUT1 controls a transcriptional and epigenetic machinery regulating endocrine development, involved in a spectrum of diabetes, encompassing monogenic (recessive and dominant) as well as multifactorial inheritance. Our findings highlight the broad contribution of ONECUT1 in diabetes pathogenesis, marking an important step toward precision diabetes medicine.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34663987 PMCID: PMC9356324 DOI: 10.1038/s41591-021-01502-7
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 87.241